Cell-Free DNA: Unveiling the Future of Cancer Diagnostics and Monitoring-Reference-Cited by-同舟云学术

Cell-Free DNA: Unveiling the Future of Cancer Diagnostics and Monitoring

Published:2024-02-04 Issue:3 Volume:16 Page:662
ISSN:2072-6694
Container-title:Cancers
language:en
Short-container-title:Cancers

Author:

Francini Edoardo¹^ORCID,Nuzzo Pier Vitale²^ORCID,Fanelli Giuseppe Nicolò³^ORCID

Affiliation:

1. Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy

2. Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10065, USA

3. Division of Pathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy

Abstract

As we conclude this Special Issue of 21 published articles dedicated to cell-free DNA (cfDNA) as a prognostic and predictive biomarker in solid cancers, we find ourselves gazing at a vibrant landscape of research on cfDNA [...]

Publisher

MDPI AG

Link

https://www.mdpi.com/2072-6694/16/3/662/pdf

Reference12 articles.

1. Liquid biopsy enters the clinic—Implementation issues and future challenges;Ignatiadis;Nat. Rev. Clin. Oncol.,2021

2. Liquid Biopsy: From Discovery to Clinical Application;Pantel;Cancer Discov.,2021

3. Applications of Liquid Biopsy for Surgical Patients with Cancer: A Review;Mahuron;JAMA Surg.,2024

4. Kahana-Edwin, S., Torpy, J., Cain, L.E., Mullins, A., McCowage, G., Woodfield, S.E., Vasudevan, S.A., Shea, D.P.T., Minoche, A.E., and Espinoza, A.F. (2023). Quantitative ctDNA Detection in Hepatoblastoma: Implications for Precision Medicine. Cancers, 16.

5. Lee, T., Rawding, P.A., Bu, J., Hyun, S., Rou, W., Jeon, H., Kim, S., Lee, B., Kubiatowicz, L.J., and Kim, D. (2022). Machine-Learning-Based Clinical Biomarker Using Cell-Free DNA for Hepatocellular Carcinoma (HCC). Cancers, 14.